icon
icon
icon
icon
icon
icon
icon
icon
Close browser
icon
Go back to News
NEWS

GA_P advises Andritz on the acquisition of the Salico Group

icon 30 of June, 2025

Gómez-Acebo & Pombo has advised the Austrian listed company Andritz AG on its acquisition of the Salico Group, a company specialized in the design and manufacture of finishing equipment for flat metal strips, with operations in Italy, Spain, the United Kingdom, the United States, and India

The agreement signed by Andritz, which has annual revenues of over €8 billion, strengthens its strategy to expand its global presence and enhance its technology portfolio in the downstream segment, which is key for industries such as steel and aluminum. The transaction is expected to close in the coming weeks.

The GA_P team was led by Mónica Weimann, partner in the Corporate/M&A team, together with Cristina Sánchez Weickgenannt and Guillermo Menéndez Herrero, associates. They were supported, among others, by Delia Castaños, Iratze Arrigain García, Paula García Cuevas, and Andrea González-Novo, associates from the Labour, Intellectual Property, Public Law, and Banking & Finance teams, respectively.

Lawyer mentioned

Monica Weimann – Partner

Cristina Sánchez Weickgenannt – Senior associate

See all lawyersicon
See less lawyersicon
Tipology

Deal

Areas and sectors

Corporate and M&A

Intellectual Property

Banking and Finance

Employment

Public Law and Regulated Sectors

Press contact

Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
email scuesta@ga-p.com
Madrid, (+34) 91 582 91 00
Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
email scuesta@ga-p.com
Madrid, (+34) 91 582 91 00
icon
icon

More information about
Gómez-Acebo & Pombo

News icon Publications icon
icon
icon
icon
icon
PUBLICATION
Company resolutions reached with invalid votes
Although Article 204(3)(d) places them on the same level, the erroneous counting of votes and the counting of invalid votes are very different, given that the latter requires judicial balancing.
icon 19 Jun, 2025
icon icon
PUBLICATION
Limits of the Unified Patent Court's long arm with regard to Spain (IV): the recognition and enforcement of court decisions
The Unified Patent Court has jurisdiction, in certain cases and within the limits set by the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not party to the Agreement on a Unified Patent Court. Such decisions may be recognised and enforced in those other countries, but there are cases in which such recognition and enforcement will not be appropriate.
icon 13 Jun, 2025
icon icon
PUBLICATION
Limits of the Unified Patent Court's long arm with regard to Spain (III): applicable law
The Unified Patent Court has jurisdiction, in certain cases and within the limits laid down in the Brussels Ia Regulation and the Lugano Convention, to hear actions relating to classic European patents validated in States that are not contracting parties to the Agreement on a Unified Patent Court. However, this does not mean that, when hearing such actions, the Court may apply the same rules as if the actions related to a unitary patent.
icon 12 Jun, 2025
icon icon
PUBLICATION
Limits of the Unified Patent Court's long arm with regard to Spain (II): the controversial judgment of the Court of Justice in the BSH/Electrolux case
This document sets out and criticises the doctrine established by the CJEU in its Judgment of 25 February 2025, C-339/22, BSH/Electrolux, ECLI:EU:C:2025:108. Although the dispute underlying the judgment was not brought before the UPC, the interpretation of the CJEU in the BSH/Electrolux judgment is equally applicable, since said court is equivalent to the national courts of the contracting states party to the UPC Agreement.
icon 11 Jun, 2025
icon icon
PUBLICATION
Limits of the Unified Patent Court's long arm with regard to Spain (I): international jurisdiction
Ever since coming into operation, there has been a tendency on the part of the Unified Patent Court to extend its jurisdiction to include patents that produce effects in States that are not party to the Agreement on a Unified Patent Court (the ‘UPC Agreement’ or ‘Agreement’), as is the case of the Kingdom of Spain. This phenomenon is known in specialised circles as the court's ‘long arm’. However, although in certain cases the Unified Patent Court (the ‘UPC’ or ‘Court’) does indeed have such jurisdiction, this is only possible within strict limits, limits that do not seem to be taken into consideration in a consistent manner.
icon 10 Jun, 2025
icon icon
PUBLICATION
Royal Decree 214/2025: obligation to calculate carbon footprints, draw up emission reduction plans and publicly disclose the same
Royal Decree 214/2025 does not create a new register, as its title suggests, but rather keeps and expands the one in place since 2014. What is truly new is the obligation imposed on specific companies and public bodies to calculate their carbon footprint and to draw up greenhouse gas emission reduction plans, as well as to publish the same.
icon 20 May, 2025
icon icon
PUBLICATION
Permanent incapacity, except if employee decides otherwise or if an excessive burden on employer, no longer triggers termination of contract
The obligation to accommodate the workplace for persons with a permanent incapacity has come to the fore with such incapacity no longer constituting an automatic termination-of-employment-contract event. Now, unless the employee intends otherwise, the employer has three months to make necessary adjustments or to offer a suitable vacant post, and a failure to do so that is not justified on the grounds of excessive burden means not only a breach of law with all its consequences, but also the continuation of the employer/employee relationship with all its consequences.
icon 14 May, 2025
icon icon
PUBLICATION
Automotive and Sustainable Mobility No. 26
Summary of legislative and case law developments in the automotive sector.
icon 12 May, 2025
icon icon
PUBLICATION
Pharma & Healthcare No. 43
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
icon 16 Apr, 2025
icon icon